We are live on ! Find out more
BNGO icon

Bionano Genomics
BNGO

48 hedge funds and large institutions have $38.7M invested in Bionano Genomics in 2020 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

585% more capital invested

Capital invested by funds: $5.65M → $38.7M (+$33M)

263% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 8

78% more funds holding

Funds holding: 27 → 48 (+21)

33% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 6

0% more ownership

Funds ownership: 0.01% → 0.01% (+0%)

Holders
48
Holders Change
+21
Holders Change %
+77.78%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
29
Increased
8
Reduced
6
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PVI
Pura Vida Investments
New York
+$1.31M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$976K
3
Jane Street
Jane Street
New York
+$224K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$204K
5
ECM
ExodusPoint Capital Management
New York
+$100K

Top Sellers

Rank Fund Capital Flow
1
PCM
Perkins Capital Management
Minnesota
-$306K
2
SCM
Sio Capital Management
New York
-$174K
3
VF
Virtu Financial
New York
-$164K
4
UBS Group
UBS Group
Switzerland
-$50.1K
5
JP Morgan Chase
JP Morgan Chase
New York
-$39.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
QP
26
Quilter Plc
United Kingdom
$39K +$7.85K +21 New
BMC
27
Benin Management Corp
Connecticut
$37K – – –
Susquehanna International Group
28
Susquehanna International Group
Pennsylvania
$34K +$6.73K +18 New
LPL Financial
29
LPL Financial
California
$33K +$6.73K +18 New
HW
30
Hamilton Wealth
California
$32K +$6.35K +17 New
Osaic Holdings
31
Osaic Holdings
Arizona
$31K +$6.35K +17 New
RG
32
Retirement Group
California
$30K -$747 -2 -12%
UBS Group
33
UBS Group
Switzerland
$26K -$50.1K -134 -91%
Royal Bank of Canada
34
Royal Bank of Canada
Ontario, Canada
$26K +$374 +1 +8%
Wells Fargo
35
Wells Fargo
California
$18K +$3.36K +9 +900%
IA
36
IFP Advisors
Florida
$15K +$2.99K +8 New
NSIM
37
North Star Investment Management
Illinois
$15K +$2.99K +8 New
JP Morgan Chase
38
JP Morgan Chase
New York
$13K -$39.2K -105 -94%
SFS
39
Sowell Financial Services
Arkansas
$12K +$2.62K +7 New
Morgan Stanley
40
Morgan Stanley
New York
$8K +$1.5K +4 New
APA
41
American Portfolios Advisors
New York
$7.7K +$1.5K +4 New
Bank of Montreal
42
Bank of Montreal
Ontario, Canada
$6K -$374 -1 -33%
AWM
43
AllSquare Wealth Management
New York
$6K – – –
ASN
44
Advisory Services Network
Georgia
$6K +$374 +1 +50%
IA
45
Inspire Advisors
Idaho
$6K +$1.12K +3 New
TWM
46
Tradition Wealth Management
Minnesota
$6K +$1.12K +3 New
GWM
47
Geneos Wealth Management
Colorado
$3K +$374 +1 New
NL
48
NVWM LLC
Pennsylvania
$3K +$747 +2 New
PCM
49
Perkins Capital Management
Minnesota
– -$306K -783 Closed
SCM
50
Sio Capital Management
New York
– -$174K -447 Closed
1
2
3

BNGO Hedge Fund Activity: Q4 2020 in Review

48 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics (BNGO) for Q4 2020, worth a combined $38.7M — up 585% from $5.65M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new BNGO positions and 8 closed out — a net gain of 21 holders — while 8 added to existing stakes and 6 trimmed.

The largest buyer was Pura Vida Investments, opening a new position worth an estimated $1.31M. The largest seller was Perkins Capital Management, exiting entirely with an estimated $306K sold.

  • 48 institutional investors held Bionano Genomics (BNGO) as of Q4 2020, up from 27 in Q3 2020.
  • Funds reported $38.7M of Bionano Genomics stock for Q4 2020, up 585% quarter-over-quarter.
  • 29 funds opened new Bionano Genomics positions in Q4 2020 and 8 closed out, a net change of +21 holders.
  • The largest Bionano Genomics buyer in Q4 2020 was Pura Vida Investments, an estimated $1.31M added.
  • The largest Bionano Genomics seller in Q4 2020 was Perkins Capital Management, an estimated $306K sold.

Based on aggregated 13F filings for Q4 2020.